江天化学(300927) - 2024 Q4 - 年度业绩预告

Financial Projections - The estimated net profit attributable to shareholders for 2024 is projected to be between RMB 276 million and RMB 358 million, representing a year-on-year increase of 302.64% to 422.27% compared to RMB 68.55 million in the previous year[3] - The net profit after deducting non-recurring gains and losses is expected to be between RMB 34 million and RMB 44 million, indicating a decline of 33.58% to 48.67% from RMB 66.24 million in the same period last year[3] - Basic earnings per share are forecasted to be between RMB 1.9119 and RMB 2.4799, compared to RMB 0.4748 per share in the previous year[3] - The performance forecast period is from January 1, 2024, to December 31, 2024[3] Factors Influencing Profit - The significant increase in net profit is primarily due to the acquisition of San Daya Fine Chemicals, which resulted in negative goodwill recognized as non-operating income[6] - The company faces intensified market competition, particularly in the pricing of granular urea-formaldehyde products, which has compressed profit margins[6] Financial Data and Auditing - The financial data presented is preliminary and has not yet been audited, with final figures to be disclosed in the 2024 annual report[7] - The company has communicated with its auditing firm regarding the performance forecast, and there are no discrepancies noted[5] Investor Guidance - The company emphasizes the importance of cautious decision-making by investors due to the uncertainties in the preliminary financial data[7] - The announcement was made by the board of directors on January 23, 2025[8]